| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D SRGAP2 RALGAPA2 TBC1D3C TBC1D3B CAVIN4 TBC1D3I TBC1D3G TBC1D3F | 2.41e-08 | 279 | 104 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D OBSCN SRGAP2 RALGAPA2 TBC1D3C TBC1D3B PLEKHG1 CAVIN4 IQSEC1 TBC1D3I TBC1D3G TBC1D3F | 5.73e-08 | 507 | 104 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D OBSCN SRGAP2 RALGAPA2 TBC1D3C TBC1D3B PLEKHG1 CAVIN4 IQSEC1 TBC1D3I TBC1D3G TBC1D3F | 5.73e-08 | 507 | 104 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAGI1 TPR CLIP2 MYO5B SPTBN1 CEP290 NUMA1 OBSCN FHOD3 SPAG9 SYBU SHANK3 ROCK1 TRPV4 MTCL1 DAAM1 DMD CROCC GOLGA8A | 3.52e-06 | 1099 | 104 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | structural molecule activity | TPR KRT18 ERC1 KRT85 SPTBN1 NUMA1 OBSCN EVPL FLG2 KRT87P SHANK3 LMNA LMNB1 DMD CROCC KRT36 | 1.44e-05 | 891 | 104 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.20e-05 | 11 | 104 | 3 | GO:0005247 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear lamina | 2.69e-05 | 2 | 104 | 2 | GO:0160123 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 8.85e-05 | 17 | 104 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D SRGAP2 RALGAPA2 TBC1D3C TBC1D3B CAVIN4 TBC1D3I TBC1D3G TBC1D3F | 1.57e-04 | 656 | 104 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D OBSCN SRGAP2 RALGAPA2 CIT TBC1D3C TBC1D3B PLEKHG1 CAVIN4 PIK3R2 IQSEC1 ROCK1 TBC1D3I TBC1D3G TBC1D3F | 3.59e-04 | 1418 | 104 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | GTPase binding | 5.91e-04 | 360 | 104 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.95e-04 | 130 | 104 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.15e-03 | 308 | 104 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.46e-03 | 43 | 104 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.46e-03 | 321 | 104 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.79e-03 | 428 | 104 | 8 | GO:0015631 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D RALGAPA2 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3F | 2.56e-10 | 109 | 107 | 10 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D SRGAP2 RALGAPA2 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3F | 5.78e-08 | 244 | 107 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | MYC TBC1D3 TBC1D3H TBC1D3L TBC1D3D SRGAP2 RALGAPA2 TBC1D3C TBC1D3B MAP3K5 ROCK1 TBC1D3I TBC1D3G TBC1D3F | 3.05e-07 | 499 | 107 | 14 | GO:0051345 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | DRC7 TPR CLIP2 CCDC146 CEP290 NUMA1 SRGAP2 CEP63 SRGAP2C LMNA PKHD1 ROCK1 TRPV4 MTCL1 CROCC GOLGA8A | 9.27e-07 | 720 | 107 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3 TBC1D3H TBC1D3L TBC1D3D SRGAP2 RALGAPA2 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3F | 1.36e-06 | 335 | 107 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | microtubule-based process | DRC7 TPR CLIP2 CCDC146 CEP290 NUMA1 SRGAP2 SYBU CEP63 SRGAP2C CFAP54 LMNA PKHD1 ROCK1 TRPV4 MTCL1 CROCC GOLGA8A | 7.98e-06 | 1058 | 107 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CLIP2 MYO5B KRT85 SPTBN1 NUMA1 OBSCN FHOD3 KRT87P CIT SHANK3 CAVIN4 PIK3R2 ROCK1 TRPV4 MYH16 GOLGA8A KRT36 | 8.41e-06 | 957 | 107 | 17 | GO:0097435 |
| GeneOntologyBiologicalProcess | organelle localization | MYO5B CEP290 NUMA1 SPAG9 SYBU TRIP11 CEP63 STX3 LMNA LMNB1 PKHD1 DMD CROCC GOLGA8A | 1.63e-05 | 703 | 107 | 14 | GO:0051640 |
| GeneOntologyBiologicalProcess | organelle assembly | DRC7 TPR ERICH3 TBC1D3 CCDC146 CEP290 NUMA1 OBSCN FHOD3 SHANK3 CEP63 CAVIN4 CFAP54 CLCN4 NPTXR PKHD1 CROCC GOLGA8A | 2.13e-05 | 1138 | 107 | 18 | GO:0070925 |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 2.67e-05 | 2 | 107 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 1.01e-04 | 278 | 107 | 8 | GO:0031503 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.66e-04 | 99 | 107 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.74e-04 | 100 | 107 | 5 | GO:0045103 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | MYC TBC1D3 TBC1D3H TBC1D3L TBC1D3D SRGAP2 RALGAPA2 TBC1D3C TBC1D3B MAP3K5 ROCK1 TBC1D3I TBC1D3G TBC1D3F | 1.78e-04 | 878 | 107 | 14 | GO:0051336 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DRC7 ERICH3 TBC1D3 CCDC146 CEP290 SRGAP2 SRGAP2C CFAP54 CLCN4 PKHD1 ROCK1 CROCC | 1.85e-04 | 670 | 107 | 12 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.17e-04 | 395 | 107 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DRC7 ERICH3 TBC1D3 CCDC146 CEP290 SRGAP2 SRGAP2C CFAP54 CLCN4 PKHD1 ROCK1 CROCC | 2.27e-04 | 685 | 107 | 12 | GO:0030031 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO5B SPTBN1 OBSCN FHOD3 SRGAP2 CIT SHANK3 CAVIN4 PIK3R2 IQSEC1 ROCK1 TRPV4 MYH16 DAAM1 | 2.62e-04 | 912 | 107 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | nuclear pore localization | 2.64e-04 | 5 | 107 | 2 | GO:0051664 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 2.64e-04 | 5 | 107 | 2 | GO:0021815 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO5B SPTBN1 OBSCN FHOD3 CIT SHANK3 CAVIN4 PIK3R2 IQSEC1 ROCK1 TRPV4 MYH16 DAAM1 | 2.65e-04 | 803 | 107 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TPR TBC1D3 MYO5B SPTBN1 NUMA1 FHOD3 SRGAP2 SHANK3 SRGAP2C SETD5 NPTXR PIK3R2 IQSEC1 ROCK1 SRGAP2B CROCC | 4.09e-04 | 1189 | 107 | 16 | GO:0044087 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 4.59e-04 | 189 | 107 | 6 | GO:0030216 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 4.77e-04 | 266 | 107 | 7 | GO:0033044 | |
| GeneOntologyBiologicalProcess | cilium assembly | 5.10e-04 | 444 | 107 | 9 | GO:0060271 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MYC TPR TBC1D3 ERC1 SPTBN1 NUMA1 FHOD3 CIT SHANK3 FBXO4 LMNA NPTXR PIK3R2 NCAPD2 ROCK1 TRPV4 CROCC | 5.31e-04 | 1342 | 107 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell motility involved in cerebral cortex radial glia guided migration | 5.50e-04 | 7 | 107 | 2 | GO:0021814 | |
| GeneOntologyCellularComponent | intermediate filament | 3.29e-05 | 227 | 113 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT18 CLIP2 KRT85 SPTBN1 NUMA1 OBSCN EVPL FHOD3 SYBU KRT87P CAVIN4 LMNA LMNB1 TRPV4 MTCL1 DMD GOLGA8A KRT36 | 6.03e-05 | 1179 | 113 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT18 CLIP2 KRT85 SPTBN1 NUMA1 OBSCN EVPL FHOD3 SYBU KRT87P CAVIN4 LMNA LMNB1 TRPV4 MTCL1 DMD GOLGA8A KRT36 | 6.58e-05 | 1187 | 113 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | centriolar satellite | 6.93e-05 | 128 | 113 | 6 | GO:0034451 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 9.25e-05 | 263 | 113 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT18 CLIP2 KRT85 NUMA1 EVPL SYBU KRT87P LMNA LMNB1 TRPV4 MTCL1 DMD GOLGA8A KRT36 | 3.51e-04 | 899 | 113 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | lamin filament | 4.28e-04 | 6 | 113 | 2 | GO:0005638 | |
| GeneOntologyCellularComponent | microtubule bundle | 4.28e-04 | 6 | 113 | 2 | GO:0097427 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 FAM184A KRT18 CCDC146 ERC1 CEP290 NUMA1 ANKRD26 SPAG9 CEP63 PKHD1 ROCK1 DAAM1 CROCC | 4.38e-04 | 919 | 113 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CCDC14 FAM184A KRT18 CCDC146 ERC1 CEP290 NUMA1 ANKRD26 SPAG9 CEP63 PKHD1 CROCC | 9.41e-04 | 770 | 113 | 12 | GO:0005813 |
| Domain | TBC | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3F | 6.74e-12 | 49 | 105 | 9 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3F | 1.43e-11 | 53 | 105 | 9 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3F | 2.03e-11 | 55 | 105 | 9 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3F | 2.03e-11 | 55 | 105 | 9 | IPR000195 |
| Domain | NPIP | 9.81e-09 | 14 | 105 | 5 | IPR009443 | |
| Domain | srGAP2 | 1.73e-07 | 3 | 105 | 3 | IPR030252 | |
| Domain | Cl-channel_core | 1.42e-05 | 9 | 105 | 3 | IPR014743 | |
| Domain | - | 1.42e-05 | 9 | 105 | 3 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.42e-05 | 9 | 105 | 3 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.42e-05 | 9 | 105 | 3 | IPR001807 | |
| Domain | Intermediate_filament_CS | 2.77e-05 | 63 | 105 | 5 | IPR018039 | |
| Domain | Filament | 4.95e-05 | 71 | 105 | 5 | SM01391 | |
| Domain | IF | 5.29e-05 | 72 | 105 | 5 | PS00226 | |
| Domain | Filament | 5.66e-05 | 73 | 105 | 5 | PF00038 | |
| Domain | IF | 6.87e-05 | 76 | 105 | 5 | IPR001664 | |
| Domain | CBS | 9.17e-05 | 16 | 105 | 3 | SM00116 | |
| Domain | DUF3523 | 9.36e-05 | 3 | 105 | 2 | PF12037 | |
| Domain | DUF3523 | 9.36e-05 | 3 | 105 | 2 | IPR021911 | |
| Domain | CBS_dom | 1.84e-04 | 20 | 105 | 3 | IPR000644 | |
| Domain | CBS | 1.84e-04 | 20 | 105 | 3 | PF00571 | |
| Domain | CBS | 1.84e-04 | 20 | 105 | 3 | PS51371 | |
| Domain | MADS_MEF2-like | 1.86e-04 | 4 | 105 | 2 | IPR033896 | |
| Domain | FCH | 2.46e-04 | 22 | 105 | 3 | PF00611 | |
| Domain | FCH | 2.46e-04 | 22 | 105 | 3 | SM00055 | |
| Domain | FCH_dom | 2.82e-04 | 23 | 105 | 3 | IPR001060 | |
| Domain | Lamin_tail_dom | 3.10e-04 | 5 | 105 | 2 | IPR001322 | |
| Domain | LTD | 3.10e-04 | 5 | 105 | 2 | PF00932 | |
| Domain | - | 3.10e-04 | 5 | 105 | 2 | 2.60.40.1260 | |
| Domain | F_BAR | 3.63e-04 | 25 | 105 | 3 | IPR031160 | |
| Domain | F_BAR | 3.63e-04 | 25 | 105 | 3 | PS51741 | |
| Domain | MADS | 4.63e-04 | 6 | 105 | 2 | SM00432 | |
| Domain | MADS_BOX_1 | 4.63e-04 | 6 | 105 | 2 | PS00350 | |
| Domain | SRF-TF | 4.63e-04 | 6 | 105 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 4.63e-04 | 6 | 105 | 2 | PS50066 | |
| Domain | Spectrin_repeat | 5.67e-04 | 29 | 105 | 3 | IPR002017 | |
| Domain | TF_MADSbox | 6.45e-04 | 7 | 105 | 2 | IPR002100 | |
| Domain | Spectrin/alpha-actinin | 7.61e-04 | 32 | 105 | 3 | IPR018159 | |
| Domain | SPEC | 7.61e-04 | 32 | 105 | 3 | SM00150 | |
| Domain | DAD_dom | 8.57e-04 | 8 | 105 | 2 | IPR014767 | |
| Domain | DAD | 8.57e-04 | 8 | 105 | 2 | PS51231 | |
| Domain | PH | 9.87e-04 | 278 | 105 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 1.01e-03 | 279 | 105 | 7 | PS50003 | |
| Domain | PH_domain | 1.03e-03 | 280 | 105 | 7 | IPR001849 | |
| Domain | GBD/FH3_dom | 1.67e-03 | 11 | 105 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 1.67e-03 | 11 | 105 | 2 | PS51232 | |
| Domain | PH | 1.87e-03 | 229 | 105 | 6 | PF00169 | |
| Domain | FH2 | 3.13e-03 | 15 | 105 | 2 | PS51444 | |
| Domain | FH2_Formin | 3.13e-03 | 15 | 105 | 2 | IPR015425 | |
| Domain | FH2 | 3.13e-03 | 15 | 105 | 2 | PF02181 | |
| Domain | FH2 | 3.13e-03 | 15 | 105 | 2 | SM00498 | |
| Domain | - | 6.57e-03 | 391 | 105 | 7 | 2.30.29.30 | |
| Domain | Actinin_actin-bd_CS | 7.33e-03 | 23 | 105 | 2 | IPR001589 | |
| Domain | Spectrin | 7.33e-03 | 23 | 105 | 2 | PF00435 | |
| Domain | ACTININ_2 | 7.33e-03 | 23 | 105 | 2 | PS00020 | |
| Domain | ACTININ_1 | 7.33e-03 | 23 | 105 | 2 | PS00019 | |
| Domain | IQ | 7.48e-03 | 71 | 105 | 3 | PF00612 | |
| Domain | Prefoldin | 7.78e-03 | 72 | 105 | 3 | IPR009053 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | 1.55e-06 | 99 | 81 | 7 | M46448 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MEF2B TCF7 KRT18 KRT85 SPTBN1 EVPL SPAG9 KRT87P SHANK3 MEF2D PIK3R2 ROCK1 KRT36 | 5.19e-06 | 502 | 81 | 13 | MM14537 |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 5.78e-05 | 37 | 81 | 4 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 6.44e-05 | 38 | 81 | 4 | M495 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.41e-04 | 87 | 81 | 5 | MM15351 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.76e-04 | 49 | 81 | 4 | MM15448 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SPTBN1 OBSCN ANKRD26 SRGAP2 PLEKHG1 LMNB1 PIK3R2 ROCK1 DAAM1 GOLGA8A | 2.01e-04 | 439 | 81 | 10 | MM15595 |
| Pathway | PID_CASPASE_PATHWAY | 2.06e-04 | 51 | 81 | 4 | M220 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.22e-04 | 52 | 81 | 4 | M2341 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SPTBN1 OBSCN ANKRD26 SRGAP2 CIT PLEKHG1 LMNB1 PIK3R2 ROCK1 DAAM1 | 2.46e-04 | 450 | 81 | 10 | M27078 |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 2.96e-04 | 56 | 81 | 4 | M13968 | |
| Pathway | REACTOME_MYOGENESIS | 3.39e-04 | 24 | 81 | 3 | MM15174 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 4.82e-04 | 6 | 81 | 2 | M47736 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.98e-04 | 114 | 81 | 5 | MM15361 | |
| Pathway | WP_GASTRIN_SIGNALING | 5.18e-04 | 115 | 81 | 5 | M39866 | |
| Pathway | REACTOME_MYOGENESIS | 6.00e-04 | 29 | 81 | 3 | M853 | |
| Pathway | KEGG_THYROID_CANCER | 6.00e-04 | 29 | 81 | 3 | M523 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 6.95e-04 | 70 | 81 | 4 | M41806 | |
| Pathway | WP_P38_MAPK_SIGNALING_PATHWAY | 8.81e-04 | 33 | 81 | 3 | MM15849 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 8.93e-04 | 8 | 81 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 8.93e-04 | 8 | 81 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 8.93e-04 | 8 | 81 | 2 | M27821 | |
| Pathway | WP_P38_MAPK_SIGNALING | 1.05e-03 | 35 | 81 | 3 | M39659 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3F | 1.88e-21 | 11 | 115 | 9 | 16863688 |
| Pubmed | 1.13e-10 | 4 | 115 | 4 | 8406013 | ||
| Pubmed | MAGI1 TPR CLIP2 ERC1 SPTBN1 NUMA1 SRGAP2 CCDC177 CIT TRIP11 SHANK3 MAP3K5 TDRD3 LMNB1 OSBPL3 IQSEC1 ROCK1 MTCL1 GOLGA8A | 4.22e-10 | 963 | 115 | 19 | 28671696 | |
| Pubmed | 5.66e-10 | 5 | 115 | 4 | 12604796 | ||
| Pubmed | 5.66e-10 | 5 | 115 | 4 | 8471161 | ||
| Pubmed | MYC CCDC14 MAGI1 TPR KRT18 CLIP2 SPTBN1 CEP290 EVPL MEF2D MAP3K5 PIK3R2 DMD TBC1D3F | 8.84e-10 | 486 | 115 | 14 | 20936779 | |
| Pubmed | EFCAB5 KRT18 MYO5B ERC1 SPTBN1 RSF1 NUMA1 ANKRD26 ATAD3B STX3 CLCN4 CLCN5 LMNA LMNB1 SETD5 ATAD3A NCAPD2 PKHD1 ACIN1 BOD1L1 DMD DTHD1 | 1.85e-09 | 1442 | 115 | 22 | 35575683 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 22559944 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 30762072 | ||
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 1.41e-07 | 4 | 115 | 3 | 22559943 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.41e-07 | 4 | 115 | 3 | 12359748 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.77e-07 | 74 | 115 | 6 | 16625196 | |
| Pubmed | 3.55e-07 | 360 | 115 | 10 | 33111431 | ||
| Pubmed | DRC7 TPR ERC1 SPTBN1 NUMA1 SPAG9 TRIP11 SLC38A1 LMNA LMNB1 CLCN7 CROCC | 4.30e-07 | 568 | 115 | 12 | 37774976 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR KRT18 MYO5B ERC1 CWC15 KRT85 SPTBN1 NUMA1 EVPL FLG2 CWC22 CIT ATAD3B LMNA LMNB1 ATAD3A ACIN1 | 8.51e-07 | 1257 | 115 | 17 | 36526897 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 KRT18 ERC1 MAZ SPTBN1 ANKRD26 SRGAP2 TRIP11 MEF2D PLEKHG1 OSBPL3 IQSEC1 BOD1L1 MTCL1 | 1.03e-06 | 861 | 115 | 14 | 36931259 |
| Pubmed | Multi-omics profiling visualizes dynamics of cardiac development and functions. | 1.22e-06 | 7 | 115 | 3 | 36577384 | |
| Pubmed | ANKRD26 SRGAP2 RALGAPA2 TRIP11 SLC38A1 ATAD3B PIK3R2 ROCK1 DAAM1 DMD | 1.46e-06 | 421 | 115 | 10 | 36976175 | |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 1.57e-06 | 59 | 115 | 5 | 16083285 | |
| Pubmed | Lamin B1 protein is required for dendrite development in primary mouse cortical neurons. | 1.95e-06 | 8 | 115 | 3 | 26510501 | |
| Pubmed | TPR KRT18 SPTBN1 NUMA1 SRGAP2 FLG2 CWC22 CIT LMNA LMNB1 ATAD3A ACIN1 | 2.06e-06 | 660 | 115 | 12 | 32780723 | |
| Pubmed | 2.25e-06 | 255 | 115 | 8 | 15324660 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR KRT18 ERC1 CWC15 RSF1 NUMA1 ANKRD26 PRPF38B SPAG9 SRGAP2 TRIP11 TDRD3 ACIN1 BOD1L1 | 2.66e-06 | 934 | 115 | 14 | 33916271 |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 2.92e-06 | 9 | 115 | 3 | 23115349 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR KRT18 CWC15 MAZ RSF1 NUMA1 CWC22 MEF2D ATAD3B LMNA LMNB1 ATAD3A ACIN1 BOD1L1 | 3.39e-06 | 954 | 115 | 14 | 36373674 |
| Pubmed | MAGI1 TPR ERC1 SPTBN1 NUMA1 ANKRD26 SLC38A1 LMNB1 ATAD3A NCAPD2 ROCK1 BOD1L1 | 4.21e-06 | 708 | 115 | 12 | 39231216 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.61e-06 | 281 | 115 | 8 | 28706196 | |
| Pubmed | 5.12e-06 | 131 | 115 | 6 | 28634551 | ||
| Pubmed | CLIP2 MYO5B CEP290 ANKRD26 SPAG9 RALGAPA2 SHANK3 ATAD3B ATAD3A OSBPL3 | 5.91e-06 | 493 | 115 | 10 | 15368895 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TCF7 KRT18 SPTBN1 NUMA1 FLG2 SHANK3 ATAD3B LMNA LMNB1 ATAD3A OSBPL3 | 7.72e-06 | 626 | 115 | 11 | 33644029 |
| Pubmed | CCDC14 KRT18 MYO5B ERC1 MAZ SPTBN1 CEP290 SPAG9 SLC38A1 TDRD3 PTPRG CLCN7 ROCK1 DMD | 9.96e-06 | 1049 | 115 | 14 | 27880917 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14988024 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18524819 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17488709 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11792809 | ||
| Pubmed | ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc. | 1.08e-05 | 2 | 115 | 2 | 24317511 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9367621 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16129671 | ||
| Pubmed | Roquin-2 promotes ubiquitin-mediated degradation of ASK1 to regulate stress responses. | 1.08e-05 | 2 | 115 | 2 | 24448648 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27373832 | ||
| Pubmed | Calcium-stimulated disassembly of focal adhesions mediated by an ORP3/IQSec1 complex. | 1.08e-05 | 2 | 115 | 2 | 32234213 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 37229920 | ||
| Pubmed | ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes. | 1.08e-05 | 2 | 115 | 2 | 27556514 | |
| Pubmed | Molecular characterization of the tumor-associated antigen AAA-TOB3. | 1.08e-05 | 2 | 115 | 2 | 16909202 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 35022531 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 36444616 | ||
| Pubmed | The differential expression of lamin epitopes during mouse spermatogenesis. | 1.08e-05 | 2 | 115 | 2 | 7680212 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25343989 | ||
| Pubmed | Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. | 1.08e-05 | 2 | 115 | 2 | 16034421 | |
| Pubmed | The tail domain of lamin B1 is more strongly modulated by divalent cations than lamin A. | 1.08e-05 | 2 | 115 | 2 | 25807068 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19141474 | ||
| Pubmed | Beta-strand-mediated dimeric formation of the Ig-like domains of human lamin A/C and B1. | 1.08e-05 | 2 | 115 | 2 | 33706103 | |
| Pubmed | Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells. | 1.08e-05 | 2 | 115 | 2 | 31844279 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 3453101 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31822692 | ||
| Pubmed | Protein-protein interactions between human nuclear lamins expressed in yeast. | 1.08e-05 | 2 | 115 | 2 | 7628545 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18639545 | ||
| Pubmed | Concentration-dependent lamin assembly and its roles in the localization of other nuclear proteins. | 1.08e-05 | 2 | 115 | 2 | 24523288 | |
| Pubmed | DCM associated LMNA mutations cause distortions in lamina structure and assembly. | 1.08e-05 | 2 | 115 | 2 | 28844980 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33570570 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19615282 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17210950 | ||
| Pubmed | β-Amyloid induces nuclear protease-mediated lamin fragmentation independent of caspase activation. | 1.08e-05 | 2 | 115 | 2 | 26876308 | |
| Pubmed | 1.16e-05 | 151 | 115 | 6 | 17043677 | ||
| Pubmed | 1.55e-05 | 159 | 115 | 6 | 30581152 | ||
| Pubmed | MAGI1 TPR TCF7 KRT18 MYO5B SPTBN1 NUMA1 PRPF38B CIT MEF2D LMNA LMNB1 ATAD3A PIK3R2 ACIN1 | 1.60e-05 | 1247 | 115 | 15 | 27684187 | |
| Pubmed | CCDC14 MAGI1 NPIPB11 CEP290 RSF1 PRPF38B SRGAP2 SHANK3 OSBPL3 ROCK1 MTCL1 | 1.88e-05 | 689 | 115 | 11 | 36543142 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT18 SPTBN1 CEP290 OBSCN FLG2 RALGAPA2 KRT87P SHANK3 PLEKHG1 LMNA | 1.89e-05 | 564 | 115 | 10 | 21565611 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPN3 MAGI1 KRT18 ERC1 SPTBN1 EVPL SRGAP2 TRIP11 SLC38A1 DAAM1 | 1.92e-05 | 565 | 115 | 10 | 25468996 |
| Pubmed | 1.92e-05 | 98 | 115 | 5 | 34943047 | ||
| Pubmed | 2.32e-05 | 17 | 115 | 3 | 21628590 | ||
| Pubmed | 2.72e-05 | 469 | 115 | 9 | 27634302 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.10e-05 | 477 | 115 | 9 | 31300519 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25312645 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 9256467 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 8032679 | ||
| Pubmed | Lco1 is a novel widely expressed lamin-binding protein in the nuclear interior. | 3.24e-05 | 3 | 115 | 2 | 15265697 | |
| Pubmed | A- and B-type lamins are differentially expressed in normal human tissues. | 3.24e-05 | 3 | 115 | 2 | 9243284 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 24293108 | ||
| Pubmed | Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest. | 3.24e-05 | 3 | 115 | 2 | 21383696 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 8838815 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28549128 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22664726 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 38923254 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 31248836 | ||
| Pubmed | ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly. | 3.24e-05 | 3 | 115 | 2 | 34936866 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15284226 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25375035 | ||
| Pubmed | An alternative mechanism of clathrin-coated pit closure revealed by ion conductance microscopy. | 3.24e-05 | 3 | 115 | 2 | 22564416 | |
| Pubmed | Review: nuclear lamins--structural proteins with fundamental functions. | 3.24e-05 | 3 | 115 | 2 | 10806082 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28241138 | ||
| Pubmed | [ATAD3, a vital membrane-bound mitochondrial ATPase involved in tumor progression]. | 3.24e-05 | 3 | 115 | 2 | 22192748 | |
| Pubmed | Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC-7. | 3.24e-05 | 3 | 115 | 2 | 19661288 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28744553 | ||
| Pubmed | Expression of nuclear lamins during mouse preimplantation development. | 3.24e-05 | 3 | 115 | 2 | 3046911 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 10960149 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 20004208 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 3.24e-05 | 3 | 115 | 2 | 11948212 | |
| Pubmed | Expression of the proto-oncogenes c-fos and c-myc in mdx dystrophic mouse muscle. | 3.24e-05 | 3 | 115 | 2 | 7758695 | |
| Pubmed | Dynamics of Lamins B and A/C and Nucleoporin Nup160 during Meiotic Maturation in Mouse Oocytes. | 3.24e-05 | 3 | 115 | 2 | 28374669 | |
| Interaction | YWHAG interactions | MYC MAGI1 RC3H2 KRT18 ERC1 KRT85 MAZ SPTBN1 ANKRD26 PRPF38B SRGAP2 CWC22 TRIP11 SHANK3 MEF2D MAP3K5 PLEKHG1 LMNA CLK1 OSBPL3 IQSEC1 ACIN1 BOD1L1 MTCL1 | 4.99e-08 | 1248 | 110 | 24 | int:YWHAG |
| Interaction | KRT19 interactions | CCDC14 KRT18 CCDC146 ERC1 KRT85 CEP290 ANKRD26 CEP63 PLEKHG1 LMNB1 DMD | 4.15e-07 | 282 | 110 | 11 | int:KRT19 |
| Interaction | TBC1D31 interactions | 5.99e-07 | 56 | 110 | 6 | int:TBC1D31 | |
| Interaction | NIN interactions | CCDC14 FAM184A KRT18 ERC1 BACH2 CEP290 ANKRD26 CCDC51 CIT CEP63 PLEKHG1 LMNB1 | 6.25e-07 | 359 | 110 | 12 | int:NIN |
| Interaction | CSPP1 interactions | 9.51e-07 | 96 | 110 | 7 | int:CSPP1 | |
| Interaction | RAC1 interactions | MAGI1 MYO5B SPTBN1 ANKRD26 SRGAP2 CIT SHANK3 SLC38A1 PLEKHG1 USP6 STX3 PTPRG LMNB1 CLCN7 ATAD3A OSBPL3 PIK3R2 ROCK1 DAAM1 TBC1D3F | 1.10e-06 | 1063 | 110 | 20 | int:RAC1 |
| Interaction | CCDC77 interactions | 1.34e-06 | 64 | 110 | 6 | int:CCDC77 | |
| Interaction | KIF23 interactions | MYC MYO5B ERC1 SPTBN1 RSF1 CHCHD6 PRPF38B SPAG9 FLG2 RALGAPA2 CIT ATAD3B LMNA ATAD3A CLK1 ACIN1 MTCL1 DMD | 1.14e-05 | 1031 | 110 | 18 | int:KIF23 |
| Interaction | KRT4 interactions | 2.23e-05 | 62 | 110 | 5 | int:KRT4 | |
| Interaction | NUP153 interactions | 2.46e-05 | 216 | 110 | 8 | int:NUP153 | |
| Interaction | CEP72 interactions | 2.66e-05 | 107 | 110 | 6 | int:CEP72 | |
| Interaction | SSX2IP interactions | 2.89e-05 | 288 | 110 | 9 | int:SSX2IP | |
| Interaction | KRT8 interactions | MYC CCDC14 KRT18 ERC1 ANKRD26 TRIP11 PLEKHG1 CLK1 MTCL1 DMD KRT36 | 2.97e-05 | 441 | 110 | 11 | int:KRT8 |
| Interaction | RHOQ interactions | SPTBN1 ANKRD26 SRGAP2 RALGAPA2 SLC38A1 PLEKHG1 PTPRG CLCN7 PIK3R2 ROCK1 DAAM1 | 3.03e-05 | 442 | 110 | 11 | int:RHOQ |
| Interaction | CCDC18 interactions | 3.51e-05 | 68 | 110 | 5 | int:CCDC18 | |
| Interaction | FMR1 interactions | MYC MAGI1 RC3H2 CWC15 SPTBN1 NUMA1 SHANK3 CEP63 TDRD3 FBXO4 IQSEC1 MTCL1 | 3.66e-05 | 536 | 110 | 12 | int:FMR1 |
| Interaction | DPP4 interactions | KRT18 SPTBN1 ANKRD26 TRIP11 ATAD3B PTPRG LMNB1 CLCN7 ATAD3A PIK3R2 ROCK1 | 3.79e-05 | 453 | 110 | 11 | int:DPP4 |
| Interaction | NINL interactions | CCDC14 FAM184A CCDC146 ERC1 CEP290 ANKRD26 PLEKHG1 TDRD3 ATAD3B LMNA PIK3R2 | 4.18e-05 | 458 | 110 | 11 | int:NINL |
| Interaction | RHOB interactions | MAGI1 SPTBN1 ANKRD26 RALGAPA2 CIT SLC38A1 STX3 PTPRG CLCN7 ATAD3A OSBPL3 PIK3R2 IQSEC1 ROCK1 DAAM1 | 5.15e-05 | 840 | 110 | 15 | int:RHOB |
| Interaction | CRNKL1 interactions | 5.32e-05 | 177 | 110 | 7 | int:CRNKL1 | |
| Interaction | PCNT interactions | 5.34e-05 | 241 | 110 | 8 | int:PCNT | |
| Interaction | CCDC138 interactions | 5.84e-05 | 123 | 110 | 6 | int:CCDC138 | |
| Interaction | SYNE1 interactions | 5.84e-05 | 123 | 110 | 6 | int:SYNE1 | |
| Interaction | NUP160 interactions | 6.57e-05 | 183 | 110 | 7 | int:NUP160 | |
| Interaction | SYCE1 interactions | 6.98e-05 | 127 | 110 | 6 | int:SYCE1 | |
| Interaction | CDH1 interactions | EPN3 MAGI1 KRT18 ERC1 SPTBN1 EVPL SRGAP2 TRIP11 SLC38A1 LMNA PTPRG CLCN7 ROCK1 DAAM1 | 7.51e-05 | 768 | 110 | 14 | int:CDH1 |
| Interaction | RHOC interactions | SPTBN1 ANKRD26 CIT TRIP11 SLC38A1 STX3 LMNA LMNB1 CLCN7 OSBPL3 ROCK1 DAAM1 | 8.32e-05 | 584 | 110 | 12 | int:RHOC |
| Interaction | TBCK interactions | 8.64e-05 | 82 | 110 | 5 | int:TBCK | |
| Interaction | RAD21L1 interactions | 8.83e-05 | 3 | 110 | 2 | int:RAD21L1 | |
| Interaction | CDC42 interactions | MYC MAGI1 SPTBN1 ANKRD26 CIT TRIP11 SLC38A1 PLEKHG1 USP6 ATAD3B STX3 LMNB1 CLCN7 ATAD3A PIK3R2 NCAPD2 ROCK1 DAAM1 TBC1D3F | 9.28e-05 | 1323 | 110 | 19 | int:CDC42 |
| Interaction | PHIP interactions | 1.04e-04 | 197 | 110 | 7 | int:PHIP | |
| Interaction | RHOH interactions | SPTBN1 ANKRD26 TRIP11 SLC38A1 PTPRG LMNB1 CLCN7 ATAD3A PIK3R2 ROCK1 DAAM1 | 1.13e-04 | 512 | 110 | 11 | int:RHOH |
| Interaction | PIBF1 interactions | 1.15e-04 | 200 | 110 | 7 | int:PIBF1 | |
| Interaction | NUP93 interactions | 1.15e-04 | 269 | 110 | 8 | int:NUP93 | |
| Interaction | BCAS2 interactions | 1.18e-04 | 270 | 110 | 8 | int:BCAS2 | |
| Interaction | OFD1 interactions | 1.21e-04 | 347 | 110 | 9 | int:OFD1 | |
| Interaction | EPB41L3 interactions | 1.24e-04 | 272 | 110 | 8 | int:EPB41L3 | |
| Interaction | RAC3 interactions | MYC SPTBN1 ANKRD26 SRGAP2 TRIP11 SLC38A1 LMNB1 CLCN7 OSBPL3 PIK3R2 ROCK1 DAAM1 | 1.44e-04 | 619 | 110 | 12 | int:RAC3 |
| Interaction | LATS1 interactions | MYC MAGI1 SPTBN1 CEP290 ANKRD26 TRIP11 PLEKHG1 TDRD3 LMNA ATAD3A | 1.49e-04 | 440 | 110 | 10 | int:LATS1 |
| Interaction | KIF7 interactions | 1.50e-04 | 146 | 110 | 6 | int:KIF7 | |
| Interaction | SPTBN4 interactions | 1.59e-04 | 50 | 110 | 4 | int:SPTBN4 | |
| Interaction | CAV1 interactions | MYC MAGI1 KRT18 SPTBN1 ANKRD26 TRIP11 SLC38A1 STX3 LMNA PTPRG CLCN7 PIK3R2 ACIN1 | 1.60e-04 | 724 | 110 | 13 | int:CAV1 |
| Interaction | MPHOSPH9 interactions | 1.73e-04 | 95 | 110 | 5 | int:MPHOSPH9 | |
| Interaction | AHCTF1 interactions | 1.74e-04 | 150 | 110 | 6 | int:AHCTF1 | |
| Interaction | PRNP interactions | MYC CCDC14 MAGI1 CLIP2 CWC15 NPIPB11 CEP290 RSF1 PRPF38B SRGAP2 CIT SHANK3 LMNA OSBPL3 ROCK1 MTCL1 DMD | 1.75e-04 | 1158 | 110 | 17 | int:PRNP |
| Interaction | KALRN interactions | 1.82e-04 | 96 | 110 | 5 | int:KALRN | |
| Interaction | LATS2 interactions | 1.88e-04 | 289 | 110 | 8 | int:LATS2 | |
| Interaction | SRSF2 interactions | 1.92e-04 | 290 | 110 | 8 | int:SRSF2 | |
| Interaction | MAP3K5 interactions | 1.94e-04 | 153 | 110 | 6 | int:MAP3K5 | |
| Interaction | THOC2 interactions | 2.01e-04 | 219 | 110 | 7 | int:THOC2 | |
| Interaction | NUP107 interactions | 2.12e-04 | 221 | 110 | 7 | int:NUP107 | |
| Interaction | MEF2C interactions | 2.15e-04 | 54 | 110 | 4 | int:MEF2C | |
| Interaction | MIB1 interactions | 2.16e-04 | 295 | 110 | 8 | int:MIB1 | |
| Interaction | KIAA0753 interactions | 2.23e-04 | 157 | 110 | 6 | int:KIAA0753 | |
| Interaction | SASS6 interactions | 2.39e-04 | 159 | 110 | 6 | int:SASS6 | |
| Interaction | NF2 interactions | 2.53e-04 | 383 | 110 | 9 | int:NF2 | |
| Interaction | PRC1 interactions | MYC TPR SPTBN1 RSF1 NUMA1 CHCHD6 PRPF38B CWC22 CIT SHANK3 ATAD3B LMNA LMNB1 ACIN1 MTCL1 | 2.60e-04 | 973 | 110 | 15 | int:PRC1 |
| Interaction | HAUS4 interactions | 2.65e-04 | 104 | 110 | 5 | int:HAUS4 | |
| Interaction | NAA40 interactions | TPR KRT18 ERC1 CWC15 RSF1 NUMA1 ANKRD26 PRPF38B SPAG9 SRGAP2 CIT TRIP11 TDRD3 ACIN1 BOD1L1 | 2.75e-04 | 978 | 110 | 15 | int:NAA40 |
| Interaction | DDX39B interactions | MYC CCDC146 CWC15 SPTBN1 FLG2 CIT LMNA LMNB1 ATAD3A IQSEC1 ACIN1 | 2.86e-04 | 570 | 110 | 11 | int:DDX39B |
| Interaction | CIT interactions | MAGI1 TPR ERC1 CWC15 SPTBN1 RSF1 NUMA1 PRPF38B RALGAPA2 CIT SHANK3 MAP3K5 ATAD3B LMNA LMNB1 SETD5 ACIN1 CDYL BOD1L1 | 3.02e-04 | 1450 | 110 | 19 | int:CIT |
| Interaction | YWHAH interactions | MAGI1 KRT18 ERC1 MAZ SPTBN1 CEP290 ANKRD26 SRGAP2 CWC22 TRIP11 MEF2D MAP3K5 PLEKHG1 OSBPL3 BOD1L1 MTCL1 | 3.13e-04 | 1102 | 110 | 16 | int:YWHAH |
| Interaction | NDC80 interactions | 3.15e-04 | 312 | 110 | 8 | int:NDC80 | |
| Interaction | AMOT interactions | 3.15e-04 | 312 | 110 | 8 | int:AMOT | |
| Interaction | CEP162 interactions | 3.21e-04 | 168 | 110 | 6 | int:CEP162 | |
| Interaction | PACSIN1 interactions | 3.24e-04 | 60 | 110 | 4 | int:PACSIN1 | |
| Interaction | ECT2 interactions | MYC MYO5B SPTBN1 NUMA1 PRPF38B SPAG9 RALGAPA2 CIT ATAD3B LMNA ATAD3A NCAPD2 ACIN1 BOD1L1 | 3.34e-04 | 887 | 110 | 14 | int:ECT2 |
| Interaction | POLR3C interactions | 3.43e-04 | 110 | 110 | 5 | int:POLR3C | |
| Interaction | NXF1 interactions | MYC MAGI1 TPR BACH2 MAZ SPTBN1 NUMA1 OBSCN ANKRD49 CCDC51 MEF2D LMNA ZNF544 SETD5 OSBPL3 PIK3R2 ROCK1 MTCL1 | 3.45e-04 | 1345 | 110 | 18 | int:NXF1 |
| Interaction | NUPR1 interactions | TPR KRT18 SPTBN1 NUMA1 SRGAP2 FLG2 CWC22 CIT LMNA LMNB1 ATAD3A ACIN1 | 3.53e-04 | 683 | 110 | 12 | int:NUPR1 |
| Interaction | KRT38 interactions | 3.65e-04 | 172 | 110 | 6 | int:KRT38 | |
| Interaction | YWHAQ interactions | MYC TPR KRT18 ERC1 NUMA1 ANKRD26 SPAG9 SRGAP2 TRIP11 SHANK3 MEF2D MAP3K5 LMNA LMNB1 OSBPL3 PIK3R2 | 3.67e-04 | 1118 | 110 | 16 | int:YWHAQ |
| Interaction | CDK1 interactions | 3.83e-04 | 590 | 110 | 11 | int:CDK1 | |
| Interaction | ANPEP interactions | 3.88e-04 | 174 | 110 | 6 | int:ANPEP | |
| Interaction | SPTAN1 interactions | 3.88e-04 | 496 | 110 | 10 | int:SPTAN1 | |
| Interaction | NUP133 interactions | 4.00e-04 | 175 | 110 | 6 | int:NUP133 | |
| Interaction | YWHAB interactions | MYC MAGI1 RC3H2 KRT18 ERC1 SPTBN1 ANKRD26 SRGAP2 TRIP11 SHANK3 MAP3K5 LMNB1 OSBPL3 PIK3R2 MTCL1 | 4.03e-04 | 1014 | 110 | 15 | int:YWHAB |
| Interaction | TEAD1 interactions | 4.12e-04 | 176 | 110 | 6 | int:TEAD1 | |
| Interaction | BTF3 interactions | MYC TCF7 KRT18 SPTBN1 NUMA1 FLG2 CIT SHANK3 ATAD3B LMNA LMNB1 ATAD3A OSBPL3 | 4.15e-04 | 799 | 110 | 13 | int:BTF3 |
| Interaction | CCDC61 interactions | 4.21e-04 | 27 | 110 | 3 | int:CCDC61 | |
| Interaction | RHOG interactions | MYC SPTBN1 ANKRD26 RALGAPA2 TRIP11 SLC38A1 STX3 LMNB1 CLCN7 ATAD3A OSBPL3 PIK3R2 ROCK1 DAAM1 | 4.32e-04 | 910 | 110 | 14 | int:RHOG |
| Interaction | SLC25A12 interactions | 4.47e-04 | 250 | 110 | 7 | int:SLC25A12 | |
| Interaction | CEP63 interactions | 4.51e-04 | 179 | 110 | 6 | int:CEP63 | |
| Interaction | SULF2 interactions | 4.93e-04 | 119 | 110 | 5 | int:SULF2 | |
| Interaction | LAMP2 interactions | MYC SPTBN1 SPAG9 RALGAPA2 TRIP11 SLC38A1 PTPRG LMNB1 CLCN7 ROCK1 CDYL | 5.00e-04 | 609 | 110 | 11 | int:LAMP2 |
| Interaction | SREK1 interactions | 5.07e-04 | 183 | 110 | 6 | int:SREK1 | |
| Interaction | SNRNP27 interactions | 5.21e-04 | 184 | 110 | 6 | int:SNRNP27 | |
| Interaction | SYTL4 interactions | 5.23e-04 | 68 | 110 | 4 | int:SYTL4 | |
| Interaction | STARD13 interactions | 5.23e-04 | 68 | 110 | 4 | int:STARD13 | |
| Interaction | PAXBP1 interactions | 5.32e-04 | 121 | 110 | 5 | int:PAXBP1 | |
| Interaction | RNPS1 interactions | 5.38e-04 | 425 | 110 | 9 | int:RNPS1 | |
| Interaction | KPNA2 interactions | 5.52e-04 | 519 | 110 | 10 | int:KPNA2 | |
| Interaction | DISC1 interactions | 5.76e-04 | 429 | 110 | 9 | int:DISC1 | |
| Interaction | CHD4 interactions | MYC TPR KRT18 RSF1 NUMA1 SPAG9 FLG2 CWC22 CIT ATAD3B LMNB1 ATAD3A NCAPD2 ACIN1 | 5.83e-04 | 938 | 110 | 14 | int:CHD4 |
| Interaction | KIF20A interactions | MYC SPTBN1 NUMA1 CHCHD6 SPAG9 RALGAPA2 CIT TRIP11 ATAD3B LMNA LMNB1 ATAD3A CDYL BOD1L1 GALNT6 | 5.91e-04 | 1052 | 110 | 15 | int:KIF20A |
| Interaction | RSF1 interactions | 5.95e-04 | 124 | 110 | 5 | int:RSF1 | |
| Interaction | TPH2 interactions | 6.09e-04 | 7 | 110 | 2 | int:TPH2 | |
| Interaction | CTNNA1 interactions | 6.36e-04 | 347 | 110 | 8 | int:CTNNA1 | |
| Interaction | EGF interactions | 6.36e-04 | 31 | 110 | 3 | int:EGF | |
| Interaction | FAM133B interactions | 6.36e-04 | 31 | 110 | 3 | int:FAM133B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3F | 1.64e-10 | 149 | 115 | 9 | chr17q12 |
| Cytoband | 17q12 | 5.36e-06 | 99 | 115 | 5 | 17q12 | |
| Cytoband | 12q13 | 3.19e-05 | 71 | 115 | 4 | 12q13 | |
| Cytoband | 16p12.2 | 1.12e-04 | 37 | 115 | 3 | 16p12.2 | |
| Cytoband | 16p11.2 | 1.25e-04 | 191 | 115 | 5 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 7.01e-04 | 278 | 115 | 5 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 9.52e-04 | 172 | 115 | 4 | chr16p12 | |
| GeneFamily | Chloride voltage-gated channels | 4.75e-06 | 10 | 63 | 3 | 302 | |
| GeneFamily | Lamins | 3.58e-05 | 3 | 63 | 2 | 612 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 6.79e-05 | 23 | 63 | 3 | 1288 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 7.14e-05 | 4 | 63 | 2 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.19e-04 | 5 | 63 | 2 | 1086 | |
| GeneFamily | Keratins, type I | 4.26e-03 | 28 | 63 | 2 | 608 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.77e-03 | 206 | 63 | 4 | 682 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 2.14e-07 | 97 | 113 | 7 | M14698 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SPTBN1 CEP290 NUMA1 ANKRD49 NPIPB3 PRPF38B SPAG9 TRIP11 MAP3K5 CEP63 SLC38A1 USP6 TDRD3 ZNF544 CLK1 IQSEC1 ROCK1 CDYL DAAM1 | 1.05e-06 | 1215 | 113 | 19 | M41122 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | TPR TCF7 MYO5B ERC1 KRT85 BACH2 SPTBN1 MAP3K5 PTPRG LMNB1 CLK1 NCAPD2 DMD KRT36 | 1.67e-06 | 690 | 113 | 14 | M12224 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | TPR TCF7 MYO5B ERC1 KRT85 BACH2 SPTBN1 MAP3K5 PTPRG LMNB1 CLK1 NCAPD2 DMD KRT36 | 3.82e-06 | 741 | 113 | 14 | MM1037 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | TCF7 MYO5B BACH2 SPTBN1 FHOD3 CWC22 ADAM28 SLC38A1 PLEKHG1 USP6 CLCN5 DMD | 9.00e-06 | 587 | 113 | 12 | M40869 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 9.84e-06 | 240 | 113 | 8 | M39236 | |
| Coexpression | DORSAM_HOXA9_TARGETS_DN | 1.07e-05 | 32 | 113 | 4 | M6051 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC ERC1 NPIPB3 SPAG9 SRGAP2 USP6 TDRD3 LMNB1 ARNT2 ROCK1 CDYL MTCL1 DAAM1 DMD | 1.94e-05 | 856 | 113 | 14 | M4500 |
| Coexpression | TOMIDA_METASTASIS_DN | 6.07e-05 | 18 | 113 | 3 | M2583 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3F | 2.35e-08 | 90 | 111 | 8 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | FAM184A TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G GOLGA8A TBC1D3F | 5.78e-07 | 242 | 111 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | FAM184A TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3F | 1.81e-06 | 213 | 111 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | FAM184A TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3F | 1.81e-06 | 213 | 111 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NRIP2 MAGI1 EFCAB5 TPR RC3H2 FAM184A BACH2 CEP290 RSF1 ANKRD49 ANKRD26 PRPF38B FHOD3 SPAG9 RALGAPA2 CWC22 SLC38A1 CFAP54 SETD5 ARNT2 BOD1L1 DMD | 2.04e-06 | 1370 | 111 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | FAM184A TBC1D3 TBC1D3H TBC1D3L KRT18 TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3F | 7.06e-06 | 320 | 111 | 10 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D NUMA1 FHOD3 TBC1D3C TBC1D3B SHANK3 PLEKHG1 CLCN7 ARNT2 IQSEC1 DAAM1 DMD TBC1D3G GOLGA8A TBC1D3F | 1.13e-05 | 1075 | 111 | 18 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | MAGI1 FAM184A MYO5B CEP290 ANKRD49 ANKRD26 PRPF38B FHOD3 CWC22 CIT CEP63 SLC38A1 ROCK1 BOD1L1 MTCL1 DAAM1 DMD | 1.46e-05 | 989 | 111 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D NPIPB11 TBC1D3C TBC1D3B TBC1D3G TBC1D3F | 1.70e-05 | 281 | 111 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D NPIPB11 TBC1D3C TBC1D3B TBC1D3G TBC1D3F | 1.70e-05 | 281 | 111 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MAGI1 FAM184A CEP290 ANKRD49 ANKRD26 PRPF38B CIT ROCK1 BOD1L1 | 3.78e-05 | 311 | 111 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.57e-05 | 186 | 111 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.91e-05 | 79 | 111 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k2 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | KLF11 FAM184A TBC1D3 TBC1D3H TBC1D3L KRT18 TBC1D3D SRGAP2 TBC1D3C TBC1D3B SRGAP2C STX3 SRGAP2B DAAM1 TBC1D3G GOLGA8A TBC1D3F | 9.97e-05 | 1153 | 111 | 17 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | MAGI1 TPR FAM184A BACH2 CEP290 PRPF38B FHOD3 RALGAPA2 CWC22 CIT CEP63 SLC38A1 STX3 NPTXR DMD | 1.90e-04 | 986 | 111 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | KLF11 TBC1D3 TBC1D3H TBC1D3L TBC1D3D CEP290 NUMA1 FHOD3 SPAG9 TBC1D3C TBC1D3B SHANK3 PLEKHG1 IQSEC1 DAAM1 DMD TBC1D3G GOLGA8A TBC1D3F | 2.03e-04 | 1466 | 111 | 19 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#2_top-relative-expression-ranked_200 | 2.60e-04 | 24 | 111 | 3 | gudmap_developingKidney_e11.5_ureteric bud_200_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR FAM184A ERC1 CEP290 ANKRD49 ANKRD26 PRPF38B FHOD3 CWC22 CIT ADAM28 CFAP54 SETD5 ARNT2 PKHD1 BOD1L1 GALNT6 DMD | 3.78e-04 | 1414 | 111 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAGI1 FAM184A ERC1 CEP290 NUMA1 ANKRD49 ANKRD26 FHOD3 CIT CEP63 TDRD3 BOD1L1 DMD | 4.02e-04 | 831 | 111 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR FAM184A ERC1 CEP290 ANKRD49 ANKRD26 PRPF38B FHOD3 CIT ADAM28 CFAP54 SETD5 ARNT2 BOD1L1 DMD | 4.10e-04 | 1060 | 111 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FAM184A ERICH3 CCDC146 CEP290 ANKRD26 CFAP54 OSBPL3 DMD DTHD1 | 2.32e-09 | 197 | 115 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.83e-08 | 198 | 115 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.02e-08 | 199 | 115 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.02e-08 | 199 | 115 | 8 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.10e-07 | 193 | 115 | 7 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.10e-07 | 193 | 115 | 7 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.10e-07 | 193 | 115 | 7 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.10e-07 | 193 | 115 | 7 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.61e-07 | 195 | 115 | 7 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.15e-07 | 197 | 115 | 7 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.15e-07 | 197 | 115 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 8.72e-07 | 199 | 115 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.72e-07 | 199 | 115 | 7 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.02e-07 | 200 | 115 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 9.02e-07 | 200 | 115 | 7 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.59e-06 | 150 | 115 | 6 | 6a13e4c4b9c9e54a5016573a37132465ec1c8f99 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 7.63e-06 | 181 | 115 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.65e-06 | 185 | 115 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.92e-06 | 186 | 115 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 9.19e-06 | 187 | 115 | 6 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 9.48e-06 | 188 | 115 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.01e-05 | 190 | 115 | 6 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 190 | 115 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.01e-05 | 190 | 115 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-05 | 191 | 115 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.04e-05 | 191 | 115 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.04e-05 | 191 | 115 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 192 | 115 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 193 | 115 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 194 | 115 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 194 | 115 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-05 | 194 | 115 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 194 | 115 | 6 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | severe-B_intermediate|World / disease stage, cell group and cell class | 1.17e-05 | 195 | 115 | 6 | ce4bd004ceb05a269387adfed255d7fa393afcc6 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.17e-05 | 195 | 115 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 196 | 115 | 6 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.20e-05 | 196 | 115 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 196 | 115 | 6 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 196 | 115 | 6 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 196 | 115 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.20e-05 | 196 | 115 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 196 | 115 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 197 | 115 | 6 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.24e-05 | 197 | 115 | 6 | cf72160f03105876641fa6fdc7405e339eb084c7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 197 | 115 | 6 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_T_naive|URO / Disease, condition lineage and cell class | 1.27e-05 | 198 | 115 | 6 | c07426d4119b53e58eb5f448ae364f47cac1fc5c | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.31e-05 | 199 | 115 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.31e-05 | 199 | 115 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.31e-05 | 199 | 115 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.35e-05 | 200 | 115 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_memory|Bac-SEP / Disease, condition lineage and cell class | 1.35e-05 | 200 | 115 | 6 | 7578fc9b6b8519a04c4c08fdfd3224b3df8057a2 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-05 | 200 | 115 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-05 | 131 | 115 | 5 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.40e-05 | 150 | 115 | 5 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.54e-05 | 151 | 115 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-05 | 151 | 115 | 5 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-05 | 152 | 115 | 5 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-05 | 152 | 115 | 5 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.84e-05 | 153 | 115 | 5 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.84e-05 | 153 | 115 | 5 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 4.99e-05 | 154 | 115 | 5 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-05 | 155 | 115 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-05 | 155 | 115 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 5.30e-05 | 156 | 115 | 5 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.47e-05 | 157 | 115 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-05 | 159 | 115 | 5 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 160 | 115 | 5 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.34e-05 | 162 | 115 | 5 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.92e-05 | 165 | 115 | 5 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.92e-05 | 165 | 115 | 5 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.33e-05 | 167 | 115 | 5 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-05 | 169 | 115 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 170 | 115 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.97e-05 | 170 | 115 | 5 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.19e-05 | 171 | 115 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.89e-05 | 174 | 115 | 5 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.38e-05 | 176 | 115 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 9.38e-05 | 176 | 115 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 9.89e-05 | 178 | 115 | 5 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.89e-05 | 178 | 115 | 5 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.02e-04 | 179 | 115 | 5 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-04 | 180 | 115 | 5 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 2b8447c3487b0f29e1d5ded980fe5a96dffd7a9e | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.85e-06 | 198 | 105 | 8 | 4773_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 3.85e-06 | 198 | 105 | 8 | 5334_DN | |
| Disease | muscular dystrophy (implicated_via_orthology) | 7.11e-07 | 21 | 100 | 4 | DOID:9884 (implicated_via_orthology) | |
| Disease | osteopetrosis (implicated_via_orthology) | 1.31e-06 | 7 | 100 | 3 | DOID:13533 (implicated_via_orthology) | |
| Disease | Microvillus inclusion disease | 1.14e-05 | 2 | 100 | 2 | C0341306 | |
| Disease | Dent disease (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0070247 (implicated_via_orthology) | |
| Disease | Hypertrophic Cardiomyopathy | 4.27e-05 | 57 | 100 | 4 | C0007194 | |
| Disease | skin hydration measurement | 4.81e-05 | 21 | 100 | 3 | EFO_0009586 | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 6.79e-05 | 4 | 100 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | neuromuscular disease (implicated_via_orthology) | 6.79e-05 | 4 | 100 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | Spinal Muscular Atrophy | 1.13e-04 | 5 | 100 | 2 | C0026847 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.44e-04 | 447 | 100 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.69e-04 | 6 | 100 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | influenza A (H1N1) | 2.23e-04 | 87 | 100 | 4 | EFO_1001488 | |
| Disease | acute promyelocytic leukemia (is_implicated_in) | 2.36e-04 | 7 | 100 | 2 | DOID:0060318 (is_implicated_in) | |
| Disease | progeria (implicated_via_orthology) | 3.14e-04 | 8 | 100 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Dilated | 5.85e-04 | 48 | 100 | 3 | C0007193 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 6.21e-04 | 49 | 100 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | macrophage inflammatory protein 1b measurement | 1.20e-03 | 136 | 100 | 4 | EFO_0008219 | |
| Disease | Abnormal behavior | 1.32e-03 | 16 | 100 | 2 | C0233514 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.32e-03 | 16 | 100 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Monogenic diabetes | 1.32e-03 | 16 | 100 | 2 | C3888631 | |
| Disease | ankle brachial index | 1.32e-03 | 16 | 100 | 2 | EFO_0003912 | |
| Disease | triacylglycerol 48:1 measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0010404 | |
| Disease | syndrome (implicated_via_orthology) | 1.68e-03 | 18 | 100 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 1.99e-03 | 156 | 100 | 4 | DOID:10283 (is_marker_for) | |
| Disease | CCL4 measurement | 2.08e-03 | 20 | 100 | 2 | EFO_0004751 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.14e-03 | 75 | 100 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.51e-03 | 22 | 100 | 2 | C3711387 | |
| Disease | Primary microcephaly | 2.51e-03 | 22 | 100 | 2 | C0431350 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLHDRVVSKSAVRDS | 311 | P23470 | |
| TRSQEEARKSHLARQ | 341 | Q9UKV3 | |
| RDTEHKDREELSSRE | 1186 | Q5RHP9 | |
| SEQLEFIHDVRRRSK | 641 | Q9BYV9 | |
| ALATTEEEKHEFRRR | 91 | Q96N23 | |
| RRKRHDIAQLITATE | 286 | Q9UKQ2 | |
| EERRKTLSEETRQHQ | 161 | Q9NVI7 | |
| DEERLRQERTHALKT | 136 | Q9H201 | |
| RKERDRAREEHTSAV | 241 | Q9UKT5 | |
| RERLLSASKEHQRES | 546 | Q9UDT6 | |
| RLEAELETVSRKTHD | 876 | Q9UDT6 | |
| LREKSRDTDRHRKIT | 36 | P51793 | |
| AREKNRDRPTREHTT | 71 | Q9P013 | |
| RSIHKRVSEREAALE | 2671 | P11532 | |
| AIHDRDQSETSKREL | 1016 | Q9UPS8 | |
| SVQASQKRIEERHRE | 46 | Q5BKX8 | |
| REATSERKDLNIHVR | 396 | Q49A88 | |
| KTRIELRSAREEAAH | 1281 | O14578 | |
| LRSAREEAAHRKATD | 1286 | O14578 | |
| LERSIDISRRQSKEH | 851 | Q8NB25 | |
| SKFSRENHSEIERRR | 61 | Q9HBZ2 | |
| KSHRRKRTRSVEDDE | 131 | P49759 | |
| DVITLRRHVETKVRA | 141 | Q92617 | |
| RRVHLFETQRRTKEE | 876 | Q9HBD1 | |
| LSAKATEEDHERTRR | 321 | Q8IUD2 | |
| LHLSKRREDSERSIF | 451 | Q9NS39 | |
| TLKHEAQRLERTVER | 816 | Q9Y4B5 | |
| DVITLRRHVETKVRA | 141 | F8W0I5 | |
| SLVRHKTERHNREIE | 221 | Q96SN7 | |
| DQLESTAHSRIRKER | 186 | O60271 | |
| RHGSSSVELRERINK | 196 | Q5D862 | |
| LETENRRLESKIREH | 101 | P05783 | |
| RETKRRHETRLVEID | 216 | P02545 | |
| SADNTLERREKHEKR | 1361 | Q96QZ7 | |
| ERSLDKRNREDRASH | 1441 | Q96QZ7 | |
| IRHGETLRRTKEEIN | 326 | P78386 | |
| RIRKRELKTNEDHVS | 706 | Q6DN90 | |
| INETRRKHETRLVEV | 216 | P20700 | |
| TRTERERRSEKHRDQ | 756 | Q9HCG8 | |
| ERRINHTAFRTVEIK | 111 | P51798 | |
| ERTLRDLHAKVSREE | 1656 | Q92817 | |
| ATKDRLRAHTVRHEE | 376 | P56270 | |
| IRHGETLRRTKEEIN | 141 | A6NCN2 | |
| DVITLRRHVETKVRA | 141 | A8MRT5 | |
| RRLLSEKATHVNTRD | 91 | Q8WVL7 | |
| DVITLRRHVETKVRA | 141 | O75200 | |
| DVITLRRHVETKVRA | 141 | C9JG80 | |
| KREHEGITILVRRSS | 806 | Q2PPJ7 | |
| LSHSSRRQRQEVEKE | 256 | O95502 | |
| DVITLRRHVETKVRA | 141 | A6NHN6 | |
| HESRTNTDILETLKR | 76 | Q02080 | |
| DVITLRRHVETKVRA | 141 | E5RHQ5 | |
| GVEIRRSKRHETASQ | 1756 | Q5VST9 | |
| ERLKSRIAEIHESRT | 526 | O00459 | |
| NESKLEREHKRRTST | 646 | Q8NFC6 | |
| RQREVTDHRLSEVRK | 156 | Q8IYK2 | |
| VIDKLREHENSTLDR | 316 | Q9Y4D1 | |
| ERSHIESLRNSARRK | 966 | A4FU69 | |
| EREKLRSHEDTVRLS | 1886 | Q5TZA2 | |
| RSHEDTVRLSAEKGR | 1891 | Q5TZA2 | |
| RRHTEKQKESTLTRT | 111 | Q9Y232 | |
| DRHTRELKTQVEDLN | 1781 | O15078 | |
| NHREDRSEIERLTAK | 131 | Q96MT8 | |
| LLHRDVSSREEATEK | 26 | Q8NCL4 | |
| KSRDRDRHREITNKS | 96 | P51795 | |
| AEEHEKELRSRSVSR | 491 | Q2V2M9 | |
| SEIDHKRRASATINR | 401 | Q6ZMT9 | |
| HITASKREFLRRTEV | 626 | Q8IY82 | |
| CESILERKRHDSERS | 21 | O14901 | |
| ERKRHDSERSTCSIL | 26 | O14901 | |
| FHVREKVREETNTRS | 676 | Q9NQR7 | |
| SRKRLHRIETDEEES | 1296 | Q96T23 | |
| DVITLRRHVETKVRA | 156 | F8W1W9 | |
| RDGKVISSREHVQSR | 451 | O76013 | |
| HESRTNADIIETLRK | 76 | Q14814 | |
| NTDLKERLRRIHAES | 391 | Q9H4L5 | |
| DVITLRRHVETKVRA | 141 | A6NJU9 | |
| AETRSLVEQHKRERK | 741 | Q14980 | |
| KDSERRATLHRILTE | 1046 | Q99683 | |
| DLIHGQESRRKTSRT | 141 | Q9BQI9 | |
| KHDTHRVEELERSLS | 291 | A7E2F4 | |
| HVQVDSRELDRRKTL | 101 | Q9H7E2 | |
| VRESHEKERTRAERT | 186 | Q96ER9 | |
| SISHEEQKSVRLARE | 126 | Q9BRQ6 | |
| RSSDTEENVKRRTHN | 346 | P01106 | |
| ESRSKLERAIARHEV | 36 | Q7LGA3 | |
| ENLAHSRRTREDRKV | 501 | Q9C0A6 | |
| ANVRIEEKHVRRSSV | 211 | P0DJJ0 | |
| ANVRIEEKHVRRSSV | 211 | P0DMP2 | |
| SRRKVSRHIVREEEA | 3951 | P08F94 | |
| KRSSEHIQRIDRDVS | 136 | B9A6J9 | |
| EVRSSADLRIRKSQH | 106 | Q13277 | |
| DSIDDRHRKNRETAS | 1251 | Q01082 | |
| TLSERRRELHKEVEV | 401 | Q8IYE0 | |
| RKTLSEETRQHQARA | 116 | Q5T9A4 | |
| QEHRLFERLRETVTK | 841 | Q15021 | |
| KRSSEHIQRIDRDIS | 136 | A6NDS4 | |
| KRSSEHIQRIDRDIS | 136 | P0C7X1 | |
| ESIRKDSSLNREHRA | 646 | Q9UBY0 | |
| RQHDTRPETREDRTK | 531 | Q9BYB0 | |
| KRSSEHIQRIDRDVS | 136 | A6NER0 | |
| KESERRLHERESEIV | 286 | Q9NX95 | |
| RREITSLHERNQKLT | 736 | P12270 | |
| KDQSDKHDRRRSQSI | 516 | Q5VTL8 | |
| ANVRIEEKHVRRSSV | 211 | O75044 | |
| KRRSREKHQESTTET | 346 | P36402 | |
| RKLESDVQRISNEHE | 891 | Q9H6N6 | |
| RNRQEITDKDHTVSR | 926 | Q13464 | |
| KLTEISRRHREELSD | 246 | Q15643 | |
| RLNSEKDRAREELSH | 91 | Q6NX49 | |
| SNEREKHSGRLRVTL | 71 | A0A0B4J275 | |
| KRSSEHIQRIDRDVS | 136 | A0A087WVF3 | |
| ELELSHNRRRKSDSK | 1291 | Q9ULL1 | |
| KRSSEHIQRIDRDIS | 136 | Q6DHY5 | |
| KRSSEHIQRIDRDVS | 136 | Q8IZP1 | |
| RREVTDEDTRHLSRK | 391 | Q9HBA0 | |
| DRESRRSLTNSHLEK | 46 | Q9H2H9 | |
| ERVVDKHESVEQSRR | 1011 | P35125 | |
| KRSSEHIQRIDRDVS | 136 | A0A087WXS9 | |
| KRSSEHIQRIDRDVS | 136 | Q6IPX1 | |
| ESLRTELQRAHSERK | 986 | Q9ULV0 |